V Nitti. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAdolescentAdultAminosalicylic Acids/therapeutic useAnimalsCulture MediaDrug CombinationsDrug Resistance, MicrobialEthambutol/therapeutic useFemaleGuinea PigsHumansIsoniazid/therapeutic useMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium/drug effectsMycobacterium tuberculosis/drug effectsOrgan SizeRifampin/pharmacologyRifampin/therapeutic useSpleen/drug effectsStreptomycin/therapeutic useTime FactorsTuberculosis/drug therapyTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/microbiology
Substances: See more » Aminosalicylic AcidsCulture MediaDrug CombinationsEthambutolIsoniazidRifampinStreptomycin
Year: 1970 PMID: 5002308 DOI: 10.1159/000386847
Source DB: PubMed Journal: Antibiot Chemother